Sector Update: Health Care Stocks Edge Higher in Afternoon Trading

Health care stocks were edging up Friday afternoon, with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) up less than 0.1%. The iShares Biotechnology ETF (IBB)

MT NewswiresJun 29 02:07

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:AGEN) with a Buy and maintains $40 price target.

BenzingaJun 29 01:30

Agenus Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 177.39% HC Wainwright & Co. $40 → $40 Reiterates Buy → Buy 05/24/2024 177.39% HC Wainwright & C

BenzingaJun 29 01:29

Agenus Shares Rise 12% After Positive Data From Botensilimab/Balstilimab Study

By Chris Wack Agenus shares were up 12% to $15.86 after the company said it saw positive results from an investigator-sponsored trial of botensilimab and balstilimab in the neoadjuvant setting for co

WSJJun 29 01:10

Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients

Agenus (AGEN) shares were up more than 6% in recent Friday trading after the company posted results from an investigator-sponsored trial of botensilimab and balstilimab in the neoadjuvant setting for

MT NewswiresJun 29 00:00

Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress

Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress

BenzingaJun 28 23:10